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Abstract
Background: Major depressive disorder is a leading cause of disease burden worldwide, indicating the importance of
effective therapies. Outcome studies have shown overall efficacy of different types of psychotherapy across groups, yet
large variability within groups. Although patient characteristics are considered crucial in understanding outcome, they
have received limited research attention. This trial aims at investigating the interaction between therapeutic approach
(pre-structured versus explorative) and the personality style of patients (dependent versus self-critical), which is considered
a core underlying dimension of depressive pathology.
Methods/design: This study is a pragmatic stratified (dependent and self-critical patients) parallel trial with equal
randomization (allocation 1:1) conducted in Flanders, Belgium. One hundred and four patients will be recruited and
randomized to either 16–20 sessions of cognitive behavioral therapy for depression (pre-structured approach) or 16–20
sessions of short-term psychodynamic psychotherapy for depression (explorative approach) conducted by trained
psychotherapists in private practices. The primary outcome is the severity of depression as measured by the Hamilton
Rating Scale for Depression at completion of therapy. Secondary outcome measures include self-reported depressive and
other symptoms, interpersonal functioning, idiosyncratic complaints, and the presence of the diagnosis of depression.
Additional measures include biological measures, narrative material (sessions, interviews), and health care costs.
Discussion: This trial presents the test of an often-described, yet hardly investigated interaction between important
personality dimensions and therapeutic approach in the treatment of depression. Results could inform therapists on how
to match psychotherapeutic treatments to specific personality characteristics of their patients.
Trial registration: Isrctn.com, ISRCTN17130982. Registered on 2 February 2015.
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Background
Major depressive disorder (MDD) is the leading cause of
disability worldwide and a major contributor to the over-
all global burden of disease [1]. This implies that further
development of effective therapies is essential for public
health. Therapies for MDD promoted as evidence-based
are antidepressant medication and different types of psy-
chotherapy, including cognitive behavioral therapy
(CBT) and psychodynamic therapy (PDT) [2, 3]. While
outcome studies demonstrate overall efficacy of these
therapies across groups, they also reveal substantial vari-
ability within groups between individual patients [4].
Consequently, identifying patient-treatment interaction
effects in outcome research is a major challenge in opti-
mizing the efficiency of psychotherapy.
There is preliminary evidence suggesting that the pa-
tient’s global personality structure in terms of dependency
and self-criticism predicts differential treatment response to
the basic nature of the therapy in terms of being directive
or explorative. A vast amount of empirical research from
both psychodynamic [5] and cognitive behavioral [6] points
of view identified two personality traits — dependency and
self-criticism — that both render a person vulnerable to
MDD [7]. Persons with predominantly dependent personal-
ities are characterized by interpersonal dependency and
strong wishes to be loved and protected. Depressive com-
plaints are marked by feelings of helplessness, weakness,
and intense fears of being abandoned. Persons with a pre-
dominantly self-critical personality on the other hand are
more focused on achievement and living up to their own
high standards and expectations. Depressive complaints are
more related to the experience of failure to live up to these
standards and feelings of inferiority and guilt [5, 6, 8]. It
was demonstrated that, depending on the dominant under-
lying personality traits, patients with MDD are susceptible
to specific life stressors and show distinct depressive symp-
tom patterns [9, 10]. Furthermore, recent naturalistic out-
come research [4, 7, 11–13] suggests that dependent and
self-critical MDD patients respond differently to directive
versus explorative therapies. Directive therapies such as
cognitive behavioral therapy, as the most studied directive
approach, are more “structured, present-oriented psycho-
therapies directed toward solving current problems and
teaching clients skills to modify dysfunctional thinking and
behavior [14]”. In explorative approaches, such as most psy-
chodynamically oriented psychotherapies, therapeutic inter-
ventions are tuned to the spontaneous way in which
patients present new material (for example narrative de-
scriptions of thoughts, emotions, and complaints) and their
broader (interpersonal and historical) context. Although ex-
plorative approaches withhold from directive interventions,
they are compatible with the use of a manual that pre-
scribes the set of theoretical principles and therapeutic
techniques that are used during the explorations [15, 16].
Post hoc analyses suggest that different mediators of
change are at work in dependent and self-critical patients.
Directive interventions seem to alleviate depressive symp-
toms in dependent patients because the structure and
support positively affect the interpersonal functioning of
the patients; explorative interventions appear to alleviate
depressive symptoms in self-critical patients because they
promote intrapersonal insight [4, 7, 10, 12, 13]. Further
post hoc analysis [4] even suggested that explorative ap-
proaches might inhibit therapeutic progress in dependent
patients, because they experience the lack of directedness
as a lack of support. Similarly, directive approaches might
inhibit progress in self-critical patients, because they ex-
perience the therapist’s directedness and structure as coer-
cive [4, 7, 10, 12, 13].
With the increasing emphasis on directive and struc-
tured treatment approaches, it might be of major clinical
importance to explore the way more directive and more
open treatment styles suit different personality styles. In
existing research on differential efficacy of interventions
in dependent and self-critical patients, researchers al-
ways re-analyzed data from previously executed psycho-
therapy research (see descriptions above). Judges first
distinguished between dependent and self-critical MDD
patients on the basis of pre-treatment case formulations
and subsequently studied in which types of therapy the
highest efficacy was achieved [4, 10]. Post hoc method-
ology is a valuable tool for generating new ideas; how-
ever, it lacks internal consistency to yield a firm
evidential basis [17]. Rather, this topic requires a design




The primary aim is to present an experimental test of
the main hypothesis deduced from the post hoc observa-
tions discussed above concerning differential efficacy of
directive (CBT) and explorative treatment (PDT) for dif-
ferent personality types. In this trial, the central hypoth-
esis that is tested is that there is a significant interaction
effect between type of patient (dependent versus self-
critical) and type of therapy (directive versus explorative)
in predicting outcome. More specifically, we expect that
directive treatment will yield significantly better out-
come in terms of observer-rated depression severity in
dependent compared to self-critical patients, while ex-
plorative treatment will yield significantly better out-
come in terms of observer-rated depression severity in
self-critical compared to dependent patients.
Secondary aims concern secondary outcomes such as
percentage of patients in remission and recovery, self-
reported depression, symptom severity and well-being, and
interpersonal functioning. Furthermore, mediators and
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processes of change, clinical predictors, patient perspec-
tives on change and helpful elements, impact of research
on therapists and patients, biomarkers of depression, and
long-term outcomes among others will be explored in a
number of consecutive studies following the main trial.
Study design
The study will be a pragmatic stratified (dependent and
self-critical patients) parallel trial with equal randomization
(allocation ratio 1:1) conducted in Flanders, Belgium. The
study compares a predominantly explorative and a pre-
dominantly directive intervention, namely short-term psy-
chodynamic psychotherapy for depression (STPP, [15, 18])
and cognitive behavioral therapy for depression (CBT-D,
[19, 20]) respectively. The study design as described here
adheres to the Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) guidelines [21, 22], in-
cluding a SPIRIT flow diagram (Fig. 1), SPIRIT schedule
(Table 1), and checklist (Additional file 1).
Participants/eligibility criteria
We will recruit adult patients living in Flanders, Belgium
with a depressive disorder who meet the following inclu-
sion criteria:
– Current diagnosis of MDD according to Diagnostic
and Statistical Manual of Mental Disorders, 4th
Edition (DSM-IV)
– Hamilton Rating Scale for Depression (HRSD, [23])
total score >14
– Age between 18 and 65 years old
– Sufficient knowledge of the Dutch language
– Dominance of either dependent or self-critical
personality characteristics (prototype matching
procedure [24])
Patients on antidepressant medication can still meet
inclusion criteria and can participate in the study if they
have been on a stable dose for 4 weeks or more. All
medication use and changes will be monitored in detail
throughout the study.
We aim for a representative sample (to maximize ex-
ternal validity) by keeping the exclusion criteria to a
minimum. Exclusion criteria are any of the following:
– Current diagnosis of psychosis, delusions or bipolar
disorder
– Acute suicidal risk
– Primary diagnosis of substance abuse/dependence
– Evidence of at least one clinically significant medical
condition (e.g., brain damage, degenerative
neurological condition) causing cognitive or physical
impairments that might prevent full participation in
the treatments
– Participation in another ongoing psychotherapeutic
treatment
– Explicit preference for a specific type of therapy or a
male or female therapist (which implies participants
cannot consent to the procedure of random
allocation to treatment)
Recruitment and baseline assessment
The participant flow throughout the study is shown in
Fig. 1.
Participants are recruited both by means of referrals
from general practitioners and mental health care cen-
ters, and by self-referral. Recruitment information is
spread via posters, folders, local media, and online publi-
cations (social media, etc.). All recruitment information
is focused on potential participants who experience de-
pressive complaints and have a voluntary motivation to
start psychotherapeutic treatment. Participants apply for
the study via email or telephone. After application, an
initial phone screening takes place in which the patient
is informed about the study procedure and relevant
inclusion and exclusion criteria. When there are indica-
tions of depressive complaints and the possible partici-
pant consents to the research intake procedure, baseline
assessment starts.
The baseline assessment takes place at the Faculty
of Psychology and Educational Sciences of Ghent Uni-
versity and is conducted by a team of postgraduate
research assistants trained in the respective proce-
dures. Before the first intake interview, patients re-
ceive a baseline battery of questionnaires and provide
eight saliva samples (a morning and evening sample
for 4 consecutive days) to measure baseline symptom
presence and severity, personality characteristics, and
stress levels before the first face-to-face contact with
the researcher. During the face-to-face assessment,
the Clinical Diagnostic Interview (CDI, [25]), the
HRSD [23], and the Structured Clinical Interview for
DSM-IV Axis I disorders [26] and Axis II disorders
[27] are administered in two respective interview ap-
pointments with the same researcher. The CDI is a
semi-structured interview that assesses both the
current clinical complaints and a range of current
and lifetime inter- and intrapersonal experiences. This
interview is used to rate the dependent and self-
critical personality organization by means of prototype
matching [24]. The rating takes place after the CDI
and before the HRSD and SCID to limit any possible
bias by the formal diagnosis. Three independent and
trained researchers (interviewer, one postgraduate re-
searcher, and one academic staff researcher) conduct
the prototype matching. They each score the inter-
view individually and consequently discuss their
scores. To be possibly included in the trial, a score of
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at least 3 on a scale of 1 to 5 for one of the person-
ality dimensions and a minimum of 2 points differ-
ence with the score on the other personality
dimension are required. When no agreement can be
reached, the difference in consensus scores between
dependent and self-critical personality dimensions is
less than 2 points, or there is no score of at least 3
on either dimension, patients are excluded from the
trial. The HRSD and SCID-I depression module are
used to assess severity of depressive symptoms and
the diagnosis of MDD, respectively. The SCID-I and
II are also used to assess co-morbidity and exclusion
criteria. The baseline procedure finally yields the
collection of a hair sample and a blood sample. To-
gether with the saliva samples, these form the base-
line for the biological component of the study.
When eligible for the study, patients receive further
written and oral information about the interventions
and the full research procedure and again sign the in-
formed consent form before being randomized into one
of the treatment conditions. They also indicate whether
they can be contacted again after the study to allow de-
signing additional waves in the study and extending the
follow-up period.
Patients who are not eligible for the study (either by
not meeting inclusion criteria or meeting exclusion
Fig. 1 SPIRIT flow diagram of progress through the phases of the Ghent Psychotherapy Study
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criteria), yet have a request for psychotherapy, are re-
ferred to appropriate care.
Study setting
The study is carried out by the University of Ghent, Fac-
ulty of Psychology and Educational Sciences, Department
of Psychoanalysis and Clinical Consulting (Prof. Dr. Mat-
tias Desmet, Prof. Dr. Reitske Meganck) in collaboration
with the University of Utrecht (Prof. Dr. Claudi Bockting)
and Ghent University Hospital (Prof. Dr. Chris Baeken).
The intake procedure, peri-, post- and follow-up assess-
ments all take place at Ghent University. The psycho-
therapeutic treatments take place in private practices in
the area of Ghent, a medium-sized city in Flanders,
Belgium, and are carried out by clinical psychologists with
psychotherapy training who have been additionally trained
to conduct specific treatments for the purpose of this
study. Prof. Dr. Mattias Desmet from Ghent University is
Table 1 SPIRIT schedule of enrollment, interventions, and assessments
Study period
Enrollment Allocation Post-allocation Close-out 1 Close-out 2
Time point -t1 0 t1 t2 t3 t4 t5 t6 t7 t8
Enrollment
Eligibility screening x
Informed consent x x
Allocation x
Interventions
CBT x x x




SCID I x x
SCID II x
CDI x
CCI x x x x x x
- Self-report scales:
BDI-II, SCL-90, OQ-45, IIP-32 x x x x x x x x
DASS, VAS x x x x x x x x x
Idiosyncratic scale x x x x x x x x
WAV x x
DEQ, PSI x x x x
VTCI, ECR x x
ZIL x x x
- Biological measures
Saliva samples x x x x x x x x x
Blood samples x x
Hair samples x x x
- Therapist measures
Structured report, VAS x x x
TRQ, VAS x x
t1: sessions 2–3, 5–7, 9–11, 13–15, 17–19; t2: sessions 1, 12, 16, 20; t3: session 8; t4: post; t5: 3 month follow-up; t6: 6 month follow-up; t7: 12 month follow-up; t8:
24 month follow-up
HRSD Hamilton Rating Scale for Depression, SCID I Structured Clinical Interview for DSM-IV-TR Axis I Disorders, SCID II Structured Clinical Interview for DSM-IV-TR
Axis II Disorders, CDI Clinical Diagnostic Interview, CCI Client Change Interview, BDI-II Beck Depression Inventory II, SCL-90 Symptom Checklist -90, OQ-45 Outcome
Questionnaire-45, IIP-32 Inventory of Interpersonal Problems-32, DASS Depression Anxiety Stress Scales, VAS Visual analogue scale, WAV Working Alliance Inventory,
DEQ Depressive Experiences Questionnaire, PSI Personal Style Inventory, VTCI Short Temperament and Character Inventory, ECR Experiences in Close Relationships,
ZIL Self-rating Inventory for Post Traumatic Stress Disorder, TRQ Therapist Relationship Questionnaire
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responsible for the training of the psychodynamic thera-
pists. Prof. Dr. Claudi Bockting from the University of Ut-
recht is responsible for the training of cognitive behavioral
therapists. Statistical analyses are supported by independ-
ent statisticians from the Department of Data Analysis at
Ghent University.
Interventions
Cognitive behavioral therapy (CBT)
The CBT condition consists of 16–20 sessions of CBT
for MDD based on the CBT treatment as described by
Beck [20]. Specifically, the three-phase protocol elabo-
rated by Bockting and Huibers [19] is implemented. This
CBT is structured and teaches clients skills to modify
dysfunctional thinking and behavior. The therapeutic ap-
proach encompasses a collaborative approach as a basis
for a good working alliance. Each therapy session starts
with an agenda setting; that is, the therapist helps the
client to select the problems they want to discuss. They
then focus on cognitions and beliefs that might contrib-
ute to the emotional reaction and/or problems. Socratic
questioning will be taught to examine potential cata-
strophic/negative reasoning. Behaviors that have inter-
fered with the ability to solve problems will be identified,
and alternative potential ways of coping with these situa-
tions will be explored. Usually, in most sessions they de-
velop an action plan for the following week, focused on
cognitions and/or behavior. In CBT, clients themselves
are taught the skills and tools to deal with day-to-day
problems in their lives and to enhance emotion regula-
tion. In this CBT protocol the main focus in the first
phase is on behavioral activation interventions (mainly
based on the model of Lewinsohn et al. [28]). The sec-
ond phase introduces cognitive interventions focused on
the identification of negative thoughts (in the here and
now) and challenging techniques (such as Socratic ques-
tioning). The third phase also encompasses identification
of dysfunctional beliefs, challenging techniques, and for-
mulating a personal prevention strategy.
The techniques that are used throughout the three
phases are directive interventions partly sequenced (es-
pecially the cognitive interventions) according to stand-
ard CBT techniques [19, 20, 28].
Short-term psychodynamic psychotherapy (STPP)
The STPP condition consists of 16–20 sessions and fol-
lows the unified psychodynamic protocol for depression
(UPP-depression, [18]). The UPP-depression is a principle-
based psychodynamic time-limited treatment integrating
the most effective disorder-specific treatment components
of empirically supported psychodynamic interventions for
depression. It is mainly based on the supportive-expressive
intervention continuum outlined by Luborsky [15] and
Connolly Gibbons and colleagues [16]. It has a modular
format comprising seven integrated modules and aims at a
flexible application concerning both sequence and dosage
in line with the individual patient’s needs.
The first three modules can be mainly situated in the
first phase of therapy. They respectively focus on prepar-
ing the patient for psychotherapy, i.e., presenting a ra-
tionale and familiarizing the patient with the treatment
process; motivating the patient and setting treatment
goals, including a discussion of possible ambivalence to-
wards treatment and change; and educating and empow-
ering the patient to become an active participant in
treatment.
The two main treatment modules comprise the two
dominant treatment principles: supportive interventions
on the one hand and expressive interventions on the
other. Therapists use the techniques in response to the
spontaneous material brought up by the patient, show-
ing the explorative rather than directive nature of the
treatment approach. Supportive interventions mainly
foster a good working alliance. Specific supportive inter-
ventions are described [15] that can be used in a differ-
entiated way depending on the amount of support
specific patients need. Expressive techniques, on the
other hand, focus on identifying, interpreting, and work-
ing through unresolved conflicts [15, 18]. The focus is
on the central relationship pattern (core conflictual rela-
tionship theme [15, 29]) and understanding symptoms
within this relational context.
Finally, in the third treatment phase, attention is paid
to termination and relapse prevention.
Therapists
Four clinical psychologists with 3 to 8 years of clinical
experience and postgraduate training in psychodynamic
psychotherapy receive 2 days of training according to
the UPP-depression [18] based on the Supportive-
Expressive Time Limited (SETL) manual for MDD pro-
posed by Luborsky [15]. Four clinical psychologists with
4 to 8 years of clinical experience and postgraduate
training in CBT receive 2 days of training in pre-
structured CBT according to the cognitive behavioral
protocol for depression by Bockting and Huibers [19],
based on the manual proposed by Beck et al. [20].
Both groups of therapists receive regular supervision
sessions (bi-weekly group supervision of 2 hours) by ex-
perienced therapists in the respective disciplines.
All therapists are blind to the research hypotheses and
the outcome of the screening measures and interviews
(see below). In both conditions, therapy length is fixed
at 16 to 20 sessions (45 minutes each).
Intervention fidelity
The extent to which the interventions are delivered as
intended, or the treatment integrity, is protected and
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investigated in a number of ways. First, therapists deliver
only the specific intervention that aligns with their basic
psychotherapy training; i.e., cognitive behavioral therapists
deliver only the CBT protocol for depression and psycho-
dynamic therapists deliver only STPP. Furthermore, the
training and regular supervision sessions aim at sufficient
competence in and adherence to the respective treatment
manuals. Each therapist also had a “training case” that is
not included in the trial that was closely supervised, so
that they could get used to both the manual and the re-
spective research procedures. All sessions were audiotaped
and thus allow explicit adherence checks. Specifically, the
Comparative Psychotherapy Process Scale [30] will be
used to reliably assess characteristics of cognitive behav-
ioral and psychodynamic-interpersonal treatments in the
respective treatments. Therapist adherence/fidelity to the
specific protocols will also be assessed.
Outcomes and study measures
Procedure
There are measurement points at intake, before the start
of therapy, at every session (limited self-report battery), at
every fourth session (extended self-report battery), post-
treatment, and at follow-up at 3 and 6 months. In the sec-
ond wave of the study, additional follow-up is planned at
12 and 24 months, which can be extended if research
means are available and if participants consent to pro-
longed follow-up. All interviews and therapy sessions are
recorded on audiotape. Therapists write semi-structured
reports of every session including an appreciation of their
ability to work along the principles of the respective man-
uals, a description of the content of the session, and self-
report scales. An overview of the full procedure and the
respective measures that are used is presented in Table 1
according to SPIRIT guidelines [21, 22].
Primary outcome
The primary outcome is the post-treatment assessment
with the HRSD [23], which is the most widely used
interview-based measure in depression studies [31]. The
interview assesses depression severity. Outcome HRSD
interviews are conducted by trained researchers who are
blind to the research hypothesis, blind to the status of
the patient (pre- or post-therapy), and thus also blind to
treatment group. These researchers also conduct the
post-treatment SCID-I interview.
Secondary outcomes
Self-report depression severity is measured by means of
the Beck Depression Inventory (BDI-II [32]), which con-
sists of 21 items and shows excellent reliability and valid-
ity. The presence of a diagnosis of depression (percentage
of patients in remission) and other Axis I disorders is
assessed post-treatment by means of the SCID-I interview
[26] conducted by the researchers who also conduct the
post-treatment HRSD interviews and thus are blind to
treatment group and treatment status.
Global symptom severity and functioning are repeatedly
measured by means of the Symptom Checklist-90 (SCL-
90-R [33]), the shortened Depression Anxiety and Stress
Scale (DASS [34]), and the Outcome Questionnaire-45
(OQ-45 [35]). Problems in interpersonal functioning are
assessed by means of the Inventory of Interpersonal
Problems-32 (IIP-32 [36]).
In line with recent recommendations [37], one to five
idiosyncratic complaints are mapped during baseline as-
sessment and rated by the participant at each session on
a visual analogue scale (VAS) of 0–10.
Other measures
In addition to the prototype matching, commonly
used measures for personality styles are included in
the study. These are the Personal Style Inventory (PSI
[38]) and the Depressive Experiences Questionnaire
(DEQ [39]). Because of validity issues [9, 40], these
are not used to categorize patients in one of the per-
sonality styles, but their administration allows further
studies on convergence of different approaches to
assess personality and compare results with other
studies.
A number of additional measures are administered to
provide more context to the other (self-report, inter-
views, and biological) measures, namely the Self-rating
Inventory for Post Traumatic Stress Disorder (ZIL [41]),
measuring trauma-related symptoms; the revised version
of the Experiences in Close Relationships questionnaire
(ECR [42]) designed to assess individual differences with
respect to attachment-related anxiety and attachment-
related avoidance; and the Short Temperament and
Character Inventory (VTCI [43]), providing a compre-
hensive assessment of personality. These are adminis-
tered a limited number of times (see Table 1). At every
session, all participants rate ten emotions on a VAS of
0–10 [44].
To map the therapeutic relationship, which is consid-
ered a crucial variable in explaining outcome [45, 46],
both therapists and patients fill out the Working Alli-
ance Inventory-Short Revised (WAI-SR [47, 48]) every
fourth session. Therapists additionally fill out the Ther-
apist Response Questionnaire (TRQ [49]), and at each
session a shortened version representing the seven main
dimensions of the TRQ on a VAS of 0–10.
Finally, the semi-structured Client Change Interview
(CCI) is administered around the 8th treatment session,
at post-treatment, and at 6 and 24 months follow-up
[50]. It inquires about experienced change, to what pa-
tients ascribe those changes, and the experience of
therapy.
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Biological measures
Biological measures comprise saliva, hair, and blood
samples collected at different time points throughout
the study (see Table 1). They will be used to assess corti-
sol levels as an indicator of stress and to explore bio-
markers for depression in a broader way.
Saliva samples are a standard and well-validated way to
measure hormonal fluctuations. They are administered
before the first intake interview, before the first therapy
session, before every fourth session, post-treatment, and at
follow-up. Each time samples are administered early
morning and late evening for 4 consecutive days [51]. Sal-
iva samples are stored at –80° until analysis.
Hair samples are a more innovative method assumed
to capture long-term systemic cortisol and consequently
long-term stress, rather than momentary cortisol levels
[52]. This relatively new method is thus less well vali-
dated than standard methods such as saliva samples.
Samples are collected before treatment, around the 8th
session, and post-treatment. A lock of about 4 mm
diameter and 1–3 cm length is collected non-invasively
by cutting it at the base of the vertex posterior of the
head. Hair samples are stored in a dark and dry place
until analysis. Cortisol concentrations in 1 cm of hair
provide an indication of average cortisol level over the
course of 1 month.
Blood samples are collected pre- and post-treatment.
An independent lab administers them before 10 a.m.
from a sober participant. Six tubes are collected: two 8-
ml serum tubes, one 2-ml fluoride tube, one 2-ml EDTA
tube, and one 9-ml EDTA tube. Screening of control
variables is conducted within 12 hours after administra-
tion using a serum subsample, the 2-ml fluoride tube,
and the 2-ml EDTA tube. The 9-ml EDTA tube is proc-
essed within 48 hours to extract DNA material, which
will be stored at −80° for possible later (epi-)genetic ana-
lyses. Three other serum subsamples are stored at −80°
for later analyses of biomarkers.
Mass spectometry techniques will be used for analyses
of the different biological measures. For saliva samples,
biomarker levels are averaged across the eight samples
(4 days) to reduce daily variations.
Health care costs
The cost-effectiveness of therapy is assessed by means of
health care cost information retrieved via the Inter-
mutualistic Agency (http://www.nic-ima.be), covering a
period starting 3 years pre-treatment until 2 years post-
treatment (which is one of the only ways to gather ob-
jective information for a longer period before the patient
entered the therapy; furthermore, it can be used to get
an objective picture of antidepressant medication use).
As these data are only useful when considered across a
longer period and they can only be retrieved in the
second wave of the study, they cannot be discussed in
the primary results of the trial, but will be discussed in
the second wave study on long-term outcome.
Randomization and concealment
A (stratified) blocked randomization procedure with per-
muted blocks and allocation concealment to distribute
dependent and self-critical patients evenly across the
two types of treatment is used. An independent statisti-
cian from the Free University in Amsterdam (The
Netherlands) generated the allocation sequence using
the R package “Block Tools” [53]. Six trained research
assistants who are blind to the allocation sequence con-
duct intake assessment. Only after the decision concern-
ing eligibility is reached, will another researcher,
unaware of any information on the patient, be contacted.
This researcher handles the assignment to a treatment
condition using the pre-generated allocation sequence.
The peri- and post-interviews and follow-up assessments
are conducted by the same research assistant who con-
ducted the intake assessment, to minimize drop-out of
the study. An independent researcher who is blind to
the interventions and the study hypotheses conducts the
primary outcome assessment (HRSD, SCID-I) immedi-
ately after treatment termination and before the post-
interview (extended CCI) by the research assistant.
Determination of sample size
Based on the literature, it can be expected that a wrong
match between personality style and treatment approach
can produce adverse treatment effects [4, 7, 10, 12, 13].
Therefore, we expect a large interaction effect between
intervention type and personality size on the primary
outcome of size 1.1 (Cohen’s d). To detect such an effect
at the 5% significance level with at least 80% power,
about 26 participants are needed in every intervention
group in both strata (i.e., about 104 participants in
total).
Data analysis
Continuous variables will be summarized with means
and standard deviations, median and interquartile
ranges, and categorical variables with frequency tables.
The post-treatment score on the HRSD is the primary
outcome. The primary hypothesis on the interaction be-
tween intervention type and personality style will be
tested using a mixed model for the post-treatment score
on the HRSD with baseline HRSD score (covariate), type
of therapy, personality style, and the interaction of type
of therapy and personality style as fixed effects and a
random effect for every therapist. The latter is included
to account for potential correlation in outcomes of pa-
tients assigned to the same therapist. Following the
intention-to-treat approach, all randomized patients will
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be included in the analysis. The proposed mixed model
approach is valid under the missing at random (MAR)
assumption.
Secondary outcomes based on interviews (SCID and
CCI) will be analyzed similarly to the primary outcome.
Secondary outcomes based on self-reports (BDI, SCL,
OQ, DASS, and idiosyncratic complaints), which are ob-
tained at multiple sessions, will be analyzed using a
mixed effects model approach with fixed effects of type
of therapy, personality style, and its interaction at every
time point; and a random effect for every therapist. The
three-way interaction between therapy type, personality
style, and time will be assessed to corroborate the pri-
mary hypothesis. The estimated evolution over time in
each therapy group for each stratum will be graphically
displayed. Effect sizes, reliable change indices (RCIs),
and clinically significant change will be reported when
possible for primary and secondary outcomes.
Ethical principles
The ethical committee of Ghent University Hospital ap-
proved the entire study design and informed consent
forms. Participants receive extensive written and oral ex-
planation of all research procedures, the implications of
their participation, and consent forms for both the
research procedures and publishing of results. An elab-
orate data management plan safeguards the careful
handling of confidential data in all stages of the research
process.
If a serious adverse event (SAE, e.g., critical suicide risk)
manifests, a Data Safety Monitoring Plan (DSMP) will be
activated to decide whether or not the patient must be re-
ferred for additional interventions (e.g., antidepressant or
other medication, residential care). Participants requiring
mental health care in any of the follow-up measurements
will be referred to adequate care.
Data management and dissemination plan
The handling of the rich data gathered within this study
is carefully planned in line with ethical considerations of
privacy and confidentiality. Contact details of partici-
pants are kept in an Excel spreadsheet together with the
study identifier in a separate locked location and are
never used to communicate to any third party other
than the researchers who require contact details to con-
tact the participants. Quantitative data are entered into
SPSS matrices throughout the study. A postdoctoral re-
searcher conducts a biweekly control of data input. After
full completion of data gathering for a participant, an
additional check is performed. All data are stored on a
secured university server, and back-ups are kept on
encrypted USB drives. Therapists use a secured server
facilitation to transfer audio files of therapy sessions to
the researchers.
The features of the study and any changes to the study
design are reported on Open Science Framework [54].
Quantitative data matrices without any identifying infor-
mation will be made available through OSF as well. All
data that imply confidentiality considerations will not be
shared publicly, but are saved on the above-mentioned
secured university server and can be accessed under spe-
cific conditions upon request.
This study results in a wealth of data allowing the in-
vestigation of research questions far beyond the primary
hypothesis. Consequently, after the primary publication
of trial results using primary and secondary outcomes, a
number of studies are planned focusing, among other
things, on triangulation (comparing different ways of
mapping personality style), process clinical predictors
(e.g., therapeutic relationship), first-person experiences
(e.g., qualitative study of the CCIs), and biomarkers for
depression.
Discussion
Depressive problems are the most widely diagnosed and
most widely investigated psychological problems. Nu-
merous outcome studies have indicated the efficacy of
psychotherapy and in some cases psychotherapy with
medication for depressive disorders [55]. Effect sizes
found in these countless randomized controlled trials
comparing different interventions or interventions with
no treatment are remarkably similar across studies.
Moreover, the famous Dodo bird verdict, stating that
there is no difference in efficacy between different types
of treatment, especially holds in the context of depres-
sion [56, 57]. Nevertheless, efficacy remains limited [58],
relapse rates remain rather high [59], and, most import-
antly, there is huge within-group variability observed in
outcome research [60, 61]. Despite these important ob-
servations, little research aims at disentangling this vari-
ability within groups. In this study we want to analyze
the effect of an important client variable in depression
theory — namely, the personality style — and contribute
to the adaptation of therapy to patient characteristics.
These patient characteristics are shown to explain a
large part of therapy outcomes [62, 63]; thus, the im-
portance of exploring possibly important patient charac-
teristics is beyond doubt. As Cuijpers [55] indicated,
“more knowledge on who benefits from which treatment
are important goals for future research (p. 292).”
Whether or not the primary hypothesis is confirmed,
the unique properties of this study combining multiple
methods and perspectives allow further in-depth explor-
ation of processes of change, and both hindering and
helpful factors in therapy. Moreover, the richness of the
quantitative, qualitative, and biological data administered
at multiple time points allows one to extend the primary
research on group level with idiographic approaches.
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Before designing the current trial, extensive piloting
(naturalistic setting, 28 cases followed throughout the
whole phase of therapy and follow-up) was done to test
and perfect research procedures that are feasible both
for participants and therapists. Also, concerning data
collection and storage, the pilot study allowed us to con-
struct a detailed manual on all the steps in the whole re-
search process to guarantee that all research assistants
can be trained and follow exactly the same procedures.
Recruitment is proceeding as planned, and several
strategies (e.g., managing social media, communication
with referrers) are implemented to manage recruitment
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